Bartter syndrome is a rare inherited kidney disorder in which the body cannot properly reabsorb salt in a specific part of the kidney, leading to dangerous losses of potassium, sodium, and chloride in the urine. The hallmark lab findings are persistently low potassium (hypokalemia) and a blood chemistry tilted toward alkalosis, all while blood pressure remains normal or even low. Several different gene mutations cause distinct subtypes, and the severity ranges from life-threatening fluid overload before birth to a milder picture that may not be diagnosed until childhood or even adulthood.
What Goes Wrong in the Kidney
Your kidneys filter an enormous volume of fluid every day and then reclaim most of the water and dissolved salts before they reach the bladder. A critical step in that reclamation happens in a stretch of tubing called the thick ascending limb of the loop of Henle. Specialized transporter proteins in the cells lining that segment pull sodium, potassium, and chloride back out of the pre-urine and return them to the bloodstream. In Bartter syndrome, mutations disable one or more of those transporters, so salt keeps flowing down the tube and eventually leaves the body.1PubMed Central. Bartter syndrome: causes, diagnosis, and treatment The net effect resembles what would happen if you took a potent loop diuretic every day: you lose salt and water, your potassium drops, and your blood becomes too alkaline.
Because the kidney senses that it is losing salt, it ramps up the renin-angiotensin-aldosterone system, the hormonal cascade that normally raises blood pressure and tells the kidney to hold on to sodium. In most conditions that activate this system, blood pressure climbs. In Bartter syndrome it does not, partly because the body also overproduces prostaglandins that dilate blood vessels, and partly because the vascular system becomes resistant to the blood-pressure-raising effects of angiotensin II.2PubMed Central. A case of adult-onset Bartter’s syndrome That combination of sky-high renin and aldosterone with stubbornly normal blood pressure is one of the clinical fingerprints clinicians look for.
Prostaglandin overproduction is not just a side effect. Early research showed that urinary prostaglandin E2 levels in people with Bartter syndrome were roughly two to four times the upper limit of normal, and that these prostaglandins were driving much of the excess renin and aldosterone release.3PubMed. Bartter’s syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis That discovery led directly to one of the most effective treatments, which we’ll get to later.
Types and Genetic Causes
Because several different proteins work together to move salt in the thick ascending limb, a mutation in any one of them can produce the syndrome. Researchers classify the subtypes by which gene is affected. Types 1 through 4 follow an autosomal recessive inheritance pattern, meaning a child must inherit a faulty copy of the gene from each parent to develop the disease. Type 5, the most recently described form, is X-linked and transient, meaning it predominantly affects boys and tends to resolve on its own after birth.4PubMed Central. Genetic Heterogeneity in Bartter Syndrome: Clinical and Practical Importance
The clinical picture tracks loosely with the genetic subtype. Types 1 and 2 tend to present before birth or in the newborn period with severe salt and water losses. Type 3, often called “classic” Bartter syndrome, usually shows up in infancy or early childhood with failure to thrive, vomiting, and dehydration. Type 4 involves mutations in barttin, a protein subunit shared by chloride channels in both the kidney and the inner ear, which is why it uniquely causes sensorineural hearing loss in addition to the kidney problems. Type 5 (MAGED2 mutations) can look dramatic in utero but may vanish within months of delivery. These boundaries are not always crisp, though. Clinicians sometimes see patients whose lab profile points to one subtype while their symptoms look more like another, and genetic testing occasionally reveals overlap that defies the neat numbering system.
Antenatal Bartter Syndrome
The most severe forms of Bartter syndrome announce themselves before the baby is born. The fetal kidneys produce excessive amounts of dilute urine, which floods the amniotic sac and causes polyhydramnios, a dangerous buildup of amniotic fluid. Polyhydramnios stretches the uterus, raises the risk of preterm labor, and can make the pregnancy difficult to sustain past the early third trimester.5PubMed Central. A Rare Cause of Refractory Severe Polyhydramnios: Antenatal Bartter Syndrome In one reported case, refractory polyhydramnios appeared by 31 weeks of gestation, prompting urgent investigation.
When polyhydramnios develops without an obvious fetal or placental abnormality, clinicians may suspect antenatal Bartter syndrome and test the amniotic fluid. An elevated chloride level in the fluid is usually diagnostic.6PubMed Central. Antenatal bartter syndrome: a review Prenatal recognition matters because it opens a window for intervention. Giving the mother indomethacin, a prostaglandin inhibitor, can slow fetal urine output and reduce the fluid buildup enough to prolong the pregnancy. However, indomethacin carries fetal risks of its own, including premature narrowing of the ductus arteriosus, a critical blood vessel that must stay open until delivery. Clinicians manage this by monitoring the vessel with ultrasound and adjusting the dose, a balancing act described in case reports as requiring repeated fine-tuning.7PubMed Central. Balancing Benefits and Risks of Indomethacin in the Management of Antenatal Bartter Syndrome: A Case Report
When indomethacin alone is not enough, amnioreduction, the direct drainage of excess amniotic fluid, can buy additional time. A recent report on MAGED2-related Bartter syndrome found that amnioreduction helped prolong gestation and improve neonatal outcomes, and the authors argued for integrating rapid genetic diagnosis with proactive fetal therapy in these high-risk pregnancies.8PubMed. Amnioreduction as a therapeutic strategy for MAGED2-related Bartter syndrome: prolonging gestation and improving outcomes through genetic-guided prenatal management
Classic Bartter Syndrome in Childhood
Children with the classic form (type 3) often come to medical attention because they are not growing well. They may vomit frequently, refuse food, urinate large volumes, and drink constantly. One case report described an 11-month-old with severe failure to thrive and persistent regurgitation whose blood work revealed the characteristic combination of low potassium, low chloride, low sodium, and metabolic alkalosis, all with normal blood pressure. After starting potassium supplements and indomethacin, her electrolytes normalized and she began to grow.9PubMed Central. Classic Bartter syndrome: a rare cause of failure to thrive in a child
Polyuria, the passage of abnormally large volumes of urine, is a constant feature. Children with Bartter syndrome may produce several times more urine than expected for their size, and the resulting thirst can dominate daily life. Dehydration during a stomach bug or a hot day can spiral quickly into a medical emergency because their kidneys cannot conserve water the way a healthy kidney would. Parents of children with Bartter syndrome often describe vigilance around hydration as one of the most stressful parts of managing the condition.
The Transient X-Linked Form
Type 5 Bartter syndrome, caused by mutations in a gene called MAGED2, stands apart from the other subtypes. It is X-linked, so nearly all affected infants are male. It can cause profound polyhydramnios and extremely premature delivery, yet the kidney abnormality tends to correct itself during the first months of life.10PubMed. Polyhydramnios, Transient Antenatal Bartter’s Syndrome, and MAGED2 Mutations The original description of this variant, published in the New England Journal of Medicine, identified MAGED2 mutations in 13 infants with transient antenatal Bartter syndrome and confirmed that symptoms disappeared spontaneously in those who survived.
The word “transient” can be misleading, though. A larger analysis of 54 symptomatic patients found that symptoms resolved spontaneously in only about a quarter of cases, while persistent complications appeared in roughly 40% and about a third of patients died, usually from extreme prematurity or its consequences.11PubMed. X-linked transient antenatal Bartter syndrome related to MAGED2 gene: Enriching the phenotypic description and pathophysiologic investigation So while the underlying kidney defect may self-correct, the perinatal risks are severe enough that this is considered the most dangerous form of Bartter syndrome during the period around birth. Families given the diagnosis prenatally need to understand that the kidney part of the story may have a favorable ending, but getting through delivery safely is the immediate challenge.
Hearing Loss in Type 4
Type 4 Bartter syndrome involves mutations in the gene BSND, which encodes a protein called barttin. Barttin is a supporting subunit for two chloride channels that work not only in the kidney but also in the inner ear’s stria vascularis, the tissue responsible for generating the electrical environment that sensory hair cells need to detect sound. When barttin is absent or dysfunctional, the inner ear cannot maintain its normal positive electrical potential, and the driving force that pushes potassium ions through the hair cells’ mechanosensitive channels drops. The result is profound, congenital sensorineural hearing loss.12PubMed Central. Endocochlear potential depends on Cl- channels: mechanism underlying deafness in Bartter syndrome IV
This dual involvement of the same protein in two different organs is a good example of why genetic kidney diseases sometimes come with seemingly unrelated features. A child born with both kidney salt wasting and hearing loss should raise strong suspicion for type 4 Bartter syndrome. The hearing loss does not improve with treatment of the kidney disorder; cochlear implants are typically the path forward for language development.
Magnesium and Calcium Abnormalities
Potassium gets most of the attention in Bartter syndrome, but magnesium and calcium are often disrupted as well. Some patients develop hypomagnesemia because the kidney wastes magnesium along with potassium. A study of three siblings with Bartter syndrome found elevated urinary magnesium excretion despite low plasma magnesium levels, confirming that the kidney was actively dumping magnesium it should have been retaining.13PubMed. Pathophysiological role of magnesium in familial Bartter’s syndrome Low magnesium can make hypokalemia harder to correct because magnesium is needed for potassium to stay inside cells. Clinicians managing Bartter syndrome often need to supplement both minerals simultaneously.
Calcium handling is another area where Bartter syndrome diverges from its close mimic, Gitelman syndrome. In Bartter syndrome, urinary calcium tends to be normal or high (hypercalciuria), which over time can lead to calcium deposits in the kidneys (nephrocalcinosis) or kidney stones. In Gitelman syndrome, urinary calcium is characteristically low. This difference in calcium excretion turns out to be one of the most reliable ways to tell the two conditions apart at the bedside.
How Bartter Syndrome Differs from Gitelman Syndrome
Gitelman syndrome is the condition most commonly confused with Bartter syndrome. Both cause low potassium, metabolic alkalosis, high renin and aldosterone, and normal blood pressure. Both are inherited kidney disorders. The confusion is understandable, and in some cases blood tests alone are not enough to distinguish them. But the two conditions arise from defects at different points in the kidney’s tubular system. Gitelman syndrome involves the thiazide-sensitive sodium-chloride co-transporter in the distal convoluted tubule, a segment further downstream than the thick ascending limb affected in Bartter syndrome.14Nephrology Dialysis Transplantation. Liquorice, Liddle, Bartter or Gitelman—how to differentiate?
Several practical clues help clinicians sort them out. Bartter syndrome usually presents earlier in life, often in infancy, while Gitelman syndrome may not surface until adolescence or adulthood. Bartter syndrome is generally more severe, with more dramatic salt wasting and growth failure. And the calcium and magnesium patterns differ in characteristic ways: Bartter syndrome features normal or high urinary calcium and sometimes normal magnesium, while Gitelman syndrome features low urinary calcium and low magnesium. An early study subdivided 34 patients into two groups using a urine calcium-to-creatinine ratio cutoff. Those above the threshold had Bartter syndrome, and those below it, combined with low plasma magnesium, had Gitelman syndrome.15PubMed. Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes
When clinical and biochemical clues are ambiguous, a diuretic challenge test can help. Measuring how the kidney responds to furosemide versus hydrochlorothiazide reveals which transporter is defective. In Gitelman syndrome, the response to hydrochlorothiazide is blunted because the target transporter is already non-functional, while in most forms of Bartter syndrome, it is the furosemide-sensitive transporter that is impaired.16PubMed Central. Bartter and Gitelman syndromes: Spectrum of clinical manifestations caused by different mutations Genetic testing has increasingly become the definitive way to settle the question, but the clinical distinction still matters in settings where genetic results take weeks or months to return.
Treatment
There is no cure for the underlying genetic defect in Bartter syndrome (with one dramatic exception, discussed below). Treatment focuses on replacing what the kidney loses and on reducing the prostaglandin overproduction that worsens the cycle. Most patients take oral potassium chloride supplements, sometimes in large doses, to keep serum potassium at a safe level. Magnesium supplements are added when levels are low. Some patients also need sodium chloride supplementation, particularly infants with the antenatal forms who are losing salt rapidly.
The most effective pharmacological intervention is a class of drugs called prostaglandin synthesis inhibitors, with indomethacin being the workhorse. By blocking cyclooxygenase enzymes, indomethacin reduces prostaglandin production, which in turn lowers renin and aldosterone and decreases urinary salt and water losses. Clinical results can be striking. One early case report described a child whose growth had stalled for years; after starting indomethacin, his symptoms resolved and his height and weight returned to the normal range.17PubMed Central. Treatment of Bartter’s syndrome in early childhood with prostaglandin synthetase inhibitors When the drug was temporarily switched to ketoprofen, the clinical benefit continued, and the expected deterioration during the changeover confirmed that the improvement was genuinely driven by prostaglandin suppression.
Studies have also explored whether selective COX-2 inhibitors could substitute for indomethacin with fewer gastrointestinal side effects. Research on rofecoxib in patients with antenatal Bartter syndrome showed that it normalized prostaglandin E2 excretion and improved clinical and laboratory findings comparably to indomethacin.18PubMed. Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome However, some COX-2 inhibitors were later withdrawn from the market over cardiovascular concerns in adults, so indomethacin remains the most widely used option. Long-term indomethacin use carries its own risks, particularly kidney damage, gastric ulcers, and, in very young children, effects on bone growth. Clinicians try to use the lowest effective dose and monitor kidney function regularly.
Potassium-sparing diuretics like spironolactone or amiloride are sometimes added, and angiotensin-converting enzyme inhibitors may help blunt the overactive renin-angiotensin axis. The steady-state hypokalemia, even when managed, can become abruptly dangerous during episodes of vomiting, diarrhea, or any illness that accelerates fluid loss. Families and clinicians need to be prepared for those moments with clear action plans.
Long-Term Outcomes and Growth
Bartter syndrome is a lifelong condition, and even with good treatment, many patients face chronic challenges. A Korean multicenter study tracked 54 patients over a median follow-up of eight years from initial diagnosis and found that 41% had short stature, defined as height below the third percentile for age, at their last visit. Impaired kidney function was seen in six patients, four with moderate chronic kidney disease and two who had progressed to kidney failure.19PubMed Central. Long-term outcome of Bartter syndrome in 54 patients: A multicenter study in Korea Growth hormone therapy had been tried in three of the short-stature patients, but they remained below the third percentile at follow-up.
The risk of progressive kidney disease is real but not universal. Some patients maintain stable kidney function for decades. The mechanisms behind kidney deterioration are not fully understood, though chronic hypokalemia itself can cause structural kidney damage over time, and the long-term use of indomethacin may contribute. One case report described a patient who reached end-stage kidney disease where the anti-inflammatory drug used to treat the syndrome was suspected of having accelerated the decline.20PubMed. A case of living-related kidney transplantation in Bartter’s syndrome This creates a difficult clinical tension: the drug that best controls the day-to-day symptoms may, in some cases, contribute to the long-term complication you most want to avoid.
Kidney Transplantation as a Potential Cure
For the small number of patients who progress to end-stage kidney disease, kidney transplantation offers something remarkable: it can cure the syndrome entirely. Because the genetic defect lives in the native kidneys, replacing them with a healthy donor kidney eliminates the source of the problem. One reported case showed a completely uneventful post-transplant course for more than three years, with total disappearance of all Bartter syndrome features and no recurrence of the kidney scarring that had caused the original organ failure.21PubMed Central. Renal transplantation in a patient with Bartter syndrome and glomerulosclerosis
The picture is not always so clean. In at least one case, a patient who received a preemptive transplant without removal of the native kidneys continued to show metabolic abnormalities after transplantation, presumably because the diseased native kidneys kept losing salt even as the transplanted kidney worked normally.22Turkish Nephrology Dialysis Transplantation. Recurrent Hypokalemia, Hypomagnesemia and Metabolic Alkalosis Following Preemptive Renal Transplantation: Bartter Syndrome That experience led the authors to suggest that native kidney removal (nephrectomy) should be considered alongside transplantation for patients with severe, treatment-resistant Bartter syndrome. The idea of performing a major organ transplant as a cure for a condition that is not primarily about organ failure is unusual, but for patients whose quality of life is severely impaired by uncontrollable electrolyte swings, it represents a real option.
Living with Bartter Syndrome Day to Day
Managing Bartter syndrome involves more than just taking pills. The constant salt and water losses mean patients often crave salt and drink far more than their peers. Children may need to carry water and salty snacks throughout the school day. Physical activity, especially in hot weather, requires careful planning because sweat adds to the salt loss already happening through the kidneys. Some families report that teachers or coaches, unfamiliar with the condition, have questioned why a child needs so much water or so many bathroom breaks, adding a social burden to the medical one.
Blood draws for electrolyte monitoring are frequent, particularly in the first years after diagnosis when treatment is being optimized. Many children with Bartter syndrome develop a wary relationship with hospitals. Growth delays, if present, can also affect self-esteem during school years. For the subset of patients with type 4 and associated hearing loss, the management picture is significantly more complex, involving audiological care and cochlear implant teams alongside nephrologists.
Adults with Bartter syndrome face their own set of concerns. Women with the condition who become pregnant need close monitoring, as the physiological demands of pregnancy layer on top of already-stressed electrolyte regulation. Exercise tolerance can be limited by the chronic electrolyte derangement, and fatigue is a commonly reported symptom even when potassium levels are near the target range. The rarity of the condition means most general practitioners have never seen a case, so patients often become the most knowledgeable person in the room about their own disease, carrying medication lists and emergency protocols for unfamiliar emergency departments.